ProfileGDS4132 / 213627_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 91% 89% 90% 93% 91% 93% 89% 91% 92% 90% 92% 91% 90% 92% 92% 92% 94% 93% 91% 88% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101456.8391
GSM201543Muscle PCOS pioglitazone 121370.49589
GSM201544Muscle PCOS pioglitazone 161447.86190
GSM201545Muscle PCOS pioglitazone 201571.59493
GSM201829Muscle PCOS pioglitazone 231492.14191
GSM201830Muscle PCOS pioglitazon 251541.73293
GSM201831Muscle PCOS pioglitazone 271420.26689
GSM201832Muscle PCOS pioglitazone 31446.43291
GSM201833Muscle PCOS pioglitazone 41516.53392
GSM201834Muscle PCOS pioglitazone 81463.03990
GSM201835Muscle PCOS after pioglitazone 102516.12192
GSM201836Muscle PCOS after pioglitazone 122497.42391
GSM201837Muscle PCOS after pioglitazone 162428.71990
GSM201838Muscle PCOS after pioglitazone 202578.72692
GSM201839Muscle PCOS after pioglitazone 232534.50992
GSM201840Muscle PCOS after pioglitazone 252586.30292
GSM201841Muscle PCOS after pioglitazone 272642.29594
GSM201842Muscle PCOS after pioglitazone 32627.1393
GSM201843Muscle PCOS after pioglitazone 42507.33591
GSM201844Muscle PCOS after pioglitazone 82411.94188